In the current study, we identified TUC338 as a DLBCL-related lncRNA; TUC338 promoted DLBCL cell proliferation and growth both in vitro and in vivo by activating EGFR/PI3K/AKT signaling pathway. Here, PCBP2-OT1 is linked to diffuse large B-cell lymphoma.